Cannabis Science Inc.
Cannabis Science Inc.
Home
About Us
Corporate Overview
Mission Statement
Cannabis Science Team
Careers & Corporate Culture
iCannabinoid
Join Now!
R&D
The Science of Cannabinoids
CBIS Cannabinoid Research
Critical Ailments
COLLABORATIONS & PROJECTS
CBIS Medical Consortium
Global Economic Development
Pan African A & C University
African Economic Initiative
American States University
North American Economic Initiative
Dana-Farber
CFA
Stellenbosch University
CBIS Bottle It
Products & Pharmacies
Products
Order Online
Pharmacies
Investors
CBIS Current Share Structure
SEC Filings
Media
CBIS News Releases
CBIS In The News
CBIS Events
Contact
latest Articles
Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth
Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations
CBIS LATEST NEWS.
Home
2016
2018
-
2017
-
2016
-
2015
-
2014
-
2013
-
2012
-
2011
-
2010
-
2009
Warning
: Creating default object from empty value in
/home/cannabisscience/public_html/plugins/system/t3/base-bs3/html/com_content/category/default_articles.php
on line
17
Title
Published Date
Cannabis Science CEO Launches Raymond C. Dabney University (RCDU) and Releases Schematics for Approx. 40 Acres (1.5 Million Sq. Ft.) With the McDermitt Indian Reservation for the Nevada Drug Development Complex
06-05-16
Cannabis Science Rises to the Occasion, as the DEA Signals Signs of the Times; Approves Landmark Clinical Trial, Potential Harborside Resolution, and the DEA's Possible Decision to Re-Schedule Sooner Than We Think
12-06-16
Cannabis Science CEO Sees Over 3,000 Shareholders Registering for Their Loyalty Gifts, as the Company Looks at Plans Coming Together to Unveil the Schematics of Its 360,000 sq. ft. Nevada Drug Development Complex Within the Next Few Days
03-05-16
Cannabis Science Congratulates and Welcomes the State of Pennsylvania as the 24th State to Legalize Medical Cannabis
18-04-16
Cannabis Science CEO Pleasantly Surprised That Over 1,000 Investors in the First 48 Hours Have Registered Successfully for the Gift Shares; Nevada Property Forges Forward With Updated Renderings and Land Parcel Schematics
14-04-16
Cannabis Science CEO Unveils Loyalty Gift Procedure at 12:00 NOON PDT and Releases Development Updates on the 360,000 Sq. Ft. Nevada Research Complex Including University, Cultivation Centers, Formulation Laboratory, and Medical Clinic
11-04-16
Cannabis Science Is Very Excited as the DEA Considers to Reschedule Marijuana/Cannabis With a Landmark Decision as Early as Mid-Year, 2016
06-04-16
The Cannabis Science 360,000 Sq. Ft., Drug Development Compound Educational, Medical Facilities, and Laboratory in Nevada Presents a Fully Licensed Opportunity for Additional 900,000 Sq. Ft., for Investment Tender to the Qualified Public
04-04-16
Cannabis Science CEO Excited as Record Date for Gifted Shares Approaches Tomorrow, Thursday, March 31st, 2016, and the New 360,000 Sq. Ft., Nevada Facility Moves to Design Phase
30-03-16
Cannabis Science CEO Excited as Record Date for Gifted Shares Approaches Tomorrow, Thursday, March 31st, 2016, and the New 360,000 Sq. Ft., Nevada Facility Moves to Design Phase (2)
30-03-16
Start
Prev
1
2
3
4
5
6
7
Next
End